HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma

Cell Death and Disease

Volumn 4, Issue 7, 2013, Pages

  Granato, M ^a   Lacconi, V ^a   Peddis, M ^a   Lotti, L V ^a   Renzo, L D ^a   Gonnella, R ^a   Santarelli, R ^a   Trivedi, P ^a   Frati, L ^a   D'Orazi, G ^b,c   Faggioni, A ^a   Cirone, M ^a  

^a Pasteur Institute   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Bid; Cathepsin D; Dendritic cells; PEL; PES

Indexed keywords

2 PHENYLETHYNESULFONAMIDE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CATHEPSIN D; HEAT SHOCK PROTEIN 70; LIPOCORTIN 5; PEPSTATIN; PIFITRIN MU; PROPIDIUM IODIDE; PROTEIN BID; PROTEIN INHIBITOR; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG ANTAGONISM; DRUG CYTOTOXICITY; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LYSOSOME MEMBRANE; MEMBRANE PERMEABILITY; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 84881080283     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.263     Document Type: Article

References (47)

1. Li Z, Srivastava P. Heat-shock proteins. Curr Protoc Immunol 2004, Appendix 1: Appendix 1T; doi:10.1002/0471142735.ima01ts58.
2. Mjahed H, Girodon F, Fontenay M, Garrido C. Heat shock proteins in hematopoietic malignancies. Exp Cell Res 2012; 318: 1946-1958.
3. Goloudina AR, Demidov ON, Garrido C. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 2012; 325: 117-124.
4. Chatterjee M, Andrulis M, Stuhmer T, Muller E, Hofmann C, Steinbrunn T et al. The PI3K/Akt signalling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival inmultiple myeloma. Haematologica 2012; 98: 1132-1141.
5. Rerole AL, Jego G, Garrido C. Hsp70: anti-apoptotic and tumorigenic protein. Methods Mol Biol 2011; 787: 205-230.
6. Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W et al. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions. J Mol Med (Berl) 2013; 91: 219-235.
7. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukocyte Biol 2007; 81: 15-27.
8. Nylandsted J, Wick W, Hirt UA, Brand K, Rohde M, Leist M et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 2002; 62: 7139-7142.
9. Gurbuxani S, Bruey JM, Fromentin A, Larmonier N, Parcellier A, Jaattela M et al. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 2001; 20: 7478-7485.
10. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009; 36: 15-27.
11. Leu JI, Pimkina J, Pandey P, Murphy ME, George DL. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 2011; 9: 936-947.
12. Kaiser M, Kuhnl A, Reins J, Fischer S, Ortiz-Tanchez J, Schlee C et al. Antileukemic activity of the HSP70 inhibitor pifithrin-mu in acute leukemia. Blood Cancer J 2011; 1: e28.
13. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004; 200: 425-435.
14. Petersen NH, Kirkegaard T, Olsen OD, Jaattela M. Connecting Hsp70, sphingolipid metabolism and lysosomal stability. Cell Cycle 2010; 9: 2305-2309.
15. Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, Rafn B, Bottzauw T, Nielsen C et al. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res 2008; 68: 6623-6633.
16. Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 2010; 463:: 549-553.
17. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008; 27: 6434-6451.
18. Monian P, Jiang X. Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. Exp Oncol 2012; 34: 185-191.
19. Zhang H, Zhong C, Shi L, Guo Y, Fan Z. Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to Necroptosis. J Immunol 2009; 182: 6993-7000.
20. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
21. Roberg K, Kagedal K, Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 2002; 161: 89-96.
22. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886-897.
23. Choi KS. Autophagy and cancer. Exp Mol Med 2012; 44: 109-120.
24. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-598.
25. Vashishta A, Ohri SS, Vetvicka V. Pleiotropic effects of cathepsin D. Endocr Metab Immune Disord Drug Targets 2009; 9: 385-391.
26. Baumgartner HK, Gerasimenko JV, Thorne C, Ashurst LH, Barrow SL, Chvanov MA et al. Caspase-8-mediated apoptosis induced by oxidative stress is independent of the intrinsic pathway and dependent on cathepsins. Am J Physiol Gastrointest Liver Physiol 2007; 293: G296-G307.
27. Appelqvist H, Johansson AC, Linderoth E, Johansson U, Antonsson B, Steinfeld R et al. Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183. Ann Clin Lab Sci 2012; 42: 231-242.
28. Zhao K, Zhou H, Zhao X, Wolff DW, Tu Y, Liu H et al. Phosphatidic acid mediates the targeting of tBid to induce lysosomal membrane permeabilization and apoptosis. J Lipid Res 2012; 53: 2102-2114.
29. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839-843.
30. Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R et al. Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91. PloS One 2012; 7: e31732.
31. Carew JS, Espitia CM, Esquivel JA 2nd, Mahalingam D, Kelly KR, Reddy G et al. Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem 2011; 286: 6602-6613.
32. Khalil AA, Kabapy NF, Deraz SF, Smith C. Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets? Biochimica et biophysica acta 2011; 1816: 89-104.
33. Chen W, Sin SH, Wen KW, Damania B, Dittmer DP. Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS Pathog 2012; 8: e1003048.
34. Balaburski GM, Leu JI, Beeharry N, Hayik S, Andrake MD, Zhang G et al. A modified HSP70 inhibitor shows broad activity as an anticancer agent. Mol Cancer Res 2013; 11: 219-229.
35. Liberek K, Lewandowska A, Zietkiewicz S. Chaperones in control of protein disaggregation. EMBO J 2008; 27: 328-335.
36. Boulanger E, Marchio A, Hong SS, Pineau P. Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma. Haematologica 2009; 94: 1170-1174.
37. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221: 3-12.
38. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic Cell Death in Cancer Therapy. Ann Rev Immunol 2013; 31: 51-72.
39. Gottfried E, Kreutz M, Mackensen A. Tumor-induced modulation of dendritic cell function. Cytokine Growth Factor Rev 2008; 19: 65-77.
40. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004; 4: 941-952.
41. Cirone M, Lucania G, Aleandri S, Borgia G, Trivedi P, Cuomo L et al. Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells. Immunol Lett 2008; 120: 37-41.
42. Cirone M, Di Renzo L, Trivedi P, Lucania G, Borgia G, Frati L et al. Dendritic cell differentiation blocked by primary effusion lymphoma-released factors is partially restored by inhibition of P38 MAPK. Int J Immunopathol Pharmacol 2010; 23: 1079-1086.
43. Garufi A, Pistritto G, Ceci C, Di Renzo L, Santarelli R, Faggioni A et al. Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation. PloS One 2012; 7: e48342.
44. Sheng KC, Wright MD, Apostolopoulos V. Inflammatory mediators hold the key to dendritic cell suppression and tumor progression. Curr Med Chem 2011; 18: 5507-5518.
45. Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R et al. Activation of dendritic cells by tumor cell death. Oncoimmunology 2012; 1: 1218-1219.
46. Raciti M, Lotti LV, Valia S, Pulcinelli FM, Di Renzo L. JNK2 is activated during ER stress and promotes cell survival. Cell Death Dis 2012; 3: e429.
47. Cirone M, Lucania G, Bergamo P, Trivedi P, Frati L, Faggioni A. Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett 2007; 113: 40-46.